hnRNPLL: A new pancreatic ductal adenocarcinoma therapeutic target

被引：0
|
作者：
Ping, Changyun
机构：
[1] Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
hnRNPLL; pancreatic ductal adenocarcinoma (PDAC); therapeutic target;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
0701
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [41] Prolactin Receptor, a Novel Target for Pancreatic Ductal Adenocarcinoma
    Dandawate, P.
    Kaushik, G.
    Subramaniam, D.
    Ghosh, C.
    Choudhury, S.
    Standing, D.
    Ramamoorthy, P.
    Manzardo, A.
    Sayed, A.
    Banerjee, T.
    Santra, S.
    Butler, M.
    Padhye, S. B.
    Baranda, J.
    Kasi, A.
    Sun, W.
    Tawfik, O.
    Coppola, D.
    Malafa, M.
    Umar, S.
    Soares, M. J.
    Saha, S.
    Weir, S. J.
    Dhar, A.
    Jensen, R. A.
    Thomas, S. M.
    Anant, S.
    PANCREAS, 2018, 47 (10) : 1382 - 1382
  • [42] THERAPEUTIC RATIONALE TO TARGET CDK7-DEPENDENT TRANSCRIPTIONAL ADDICTION IN PANCREATIC DUCTAL ADENOCARCINOMA
    Lu, Ping
    Geng, Jing
    Wang, Yu
    Fang, Yuan
    Zhang, Lei
    Liu, Fang
    Tang, Yujie
    Wang, Liwei
    Xue, Jing
    GASTROENTEROLOGY, 2018, 154 (06) : S517 - S517
  • [43] Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma
    Alhasan, Sari F.
    Haugk, Beate
    Ogle, Laura F.
    Beale, Gary S.
    Long, Anna
    Burt, Alastair D.
    Tiniakos, Dina
    Televantou, Despina
    Coxon, Fareeda
    Newell, David R.
    Charnley, Richard
    Reeves, Helen L.
    BRITISH JOURNAL OF CANCER, 2016, 115 (07) : 797 - 804
  • [44] Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma
    Sari F Alhasan
    Beate Haugk
    Laura F Ogle
    Gary S Beale
    Anna Long
    Alastair D Burt
    Dina Tiniakos
    Despina Televantou
    Fareeda Coxon
    David R Newell
    Richard Charnley
    Helen L Reeves
    British Journal of Cancer, 2016, 115 : 797 - 804
  • [45] KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target
    Gao, Chun-Tao
    Ren, Jin
    Yu, Jie
    Li, Sheng-Nan
    Guo, Xiao-Fan
    Zhou, Yi-Zhang
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [46] Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma?
    Brunetti, Oronzo
    Silvestris, Nicola
    PANCREAS, 2020, 49 (01) : E11 - E11
  • [47] Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
    Thakur, Gitika
    Kumar, Raj
    Kim, Saet-Byul
    Lee, Sang-Yeob
    Lee, Sung-Lim
    Rho, Gyu-Jin
    BIOMEDICINES, 2021, 9 (02) : 1 - 33
  • [48] Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
    Srilatha, Mundla
    Malla, Ramarao
    Adem, Megha Priya
    Foote, Jeremy B.
    Nagaraju, Ganji Purnachandra
    SEMINARS IN CANCER BIOLOGY, 2023, 97 : 12 - 20
  • [49] GENOMIC CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA THERAPEUTIC RESPONSE
    Nagrial, A.
    Chin, V.
    Steinmann, A.
    Chou, A.
    Grimmond, S.
    Horvath, L.
    Pajic, M.
    Biankin, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 44 - 44
  • [50] STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused byTP53Mutation
    Hu, Shanshan
    Chen, Xiao
    Xu, Xiangxiang
    Zheng, Chenlei
    Huang, Wenqian
    Zhou, Yi
    Akuetteh, Percy David Papa
    Yang, Hongbao
    Shi, Keqing
    Chen, Bicheng
    Zhang, Qiyu
    FRONTIERS IN ONCOLOGY, 2020, 10
12345